Aquestive Therapeutics, Inc. Uncategorized Contracts & Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Consent Fee Letter, dated October 7, 2021, among Aquestive Therapeutics, Inc. and the Noteholder parties thereto
Aquestive Therapeutics, Inc.
Pharmaceuticals
2021
Letter Agreement between the Company and A. Ernest Toth, Jr. , effective on June 15, 2021
Aquestive Therapeutics, Inc.
Pharmaceuticals
2021
Description of Securities Registered under Section 12 of the Exchange Act
Aquestive Therapeutics, Inc.
Pharmaceuticals
2020
Collateral Agreement dated as of July 15, 2019 among Aquestive Therapeutics, Inc., as Issuer, the Other Grantors from time to time party thereto, U.S. Bank National Association,...
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2019
Agreement to Terminate CLA by and between MonoSol Rx, LLC and KemPharm, Inc., dated as of March 20, 2012
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2018
Agreement by and between MonoSol Rx, LLC and Indivior UK Limited, dated September 24, 2017
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2018
Commercial Exploitation Agreement by and between MonoSol Rx, LLC and Reckitt Benckiser Pharmaceuticals Inc., dated August 15, 2008 (as amended on August 19, 2009, November 13,...
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2018
Form of Indemnity Agreement by and between Registrant and its directors and officers
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2018
AGREEMENT by and between Medtech Products inc. and MonoSolRx LLC
Aquestive Therapeutics, Inc.
Pharmaceuticals
2007
LICENSEAGREEMENT
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2007
SUPPLYAGREEMENT
Aquestive Therapeutics, Inc.
Pharmaceuticals
IN
2007